Alzheimer; News from the web:
Research on mice suggests disease does not wipe memories, but makes them harder to access
Read all about it HERE
Alzheimer; News from the web:
Research on mice suggests disease does not wipe memories, but makes them harder to access
Read all about it HERE
Alzheimer; News from the web:
It is always a good thing to be happy but the article in the link for today is important as it shows research that indicates that early depression may boost the chances that you may get Alzheimer’s.
Read all about it HERE
Alzheimer; News from the web:
A short article in Forbes is calling on Corporate America to start helping with fighting Alzheimer’s
Read all about it HERE
Alzheimer; News from the web:
From a reader of the Washington Post:
As an Alzheimer’s advocate for 15 years, I speak from personal experience about the value of leveraging diagnostic tools when confronted with Alzheimer’s disease. A study shared at the Alzheimer’s Association International Conference in London found that underuse of imaging scans drives additional health-care costs.
Read all about it HERE
Alzheimer; News from the web:
You need to read the full article but really there is still no conclusive evidence of preventative measures that are sure fire.
Research data showed that occupational complexity in early life was associated with greater white matter integrity, meaning fewer signs of aging and higher processing speed and executive function in mid-life.
But it is not clear whether a more complex job causes these signs or white matter complexity influences career choice. It is also too early to tell whether the study participants are going to develop Alzheimer’s disease over time, but the team will continue to monitor them.
The data presented certainly point to exercise, cognitive training, and cognitive complexity in daily life as all having a positive influence in preventing decline in old age. But do scientists know anything about the underlying causes?
Read all about it HERE
Alzheimer; News from the web:
Nearly three dozen new Alzheimer’s drugs may reach the market in the next five years, researchers say.
That includes 27 drugs in phase 3 clinical trials, which are later in the drug review process. It also includes eight drugs in phase 2 clinical trials, according to an analysis by ResearchersAgainstAlzheimer’s (RA2) investigators, an UsAgainstAlzheimer’s network.
Read all about it HERE